1.0Cloudbreak Pharma, Inc.https://cloudbreakpharma.com/zhTeams Reviewhttps://cloudbreakpharma.com/zh/author/teams-review/CBT-001 - Cloudbreak Pharma, Inc.rich600338<blockquote class="wp-embedded-content" data-secret="E7WFXcrW3R"><a href="https://cloudbreakpharma.com/zh/pipeline/cbt-001/">CBT-001</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://cloudbreakpharma.com/zh/pipeline/cbt-001/embed/#?secret=E7WFXcrW3R" width="600" height="338" title="《 CBT-001 》—Cloudbreak Pharma, Inc." data-secret="E7WFXcrW3R" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script>
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
//# sourceURL=https://cloudbreakpharma.com/wp-includes/js/wp-embed.min.js
</script>Cloudbreak Therapeutics CBT-001 | Our Phase III ready drug candidate, CBT-001, would be the first drug therapy to treat pterygium.Surgery may not be the only option for pterygium patients! We're working on an eye drop that may provide relief and better quality of life for patientshttps://cloudbreakpharma.com/wp-content/uploads/2024/04/Phase-2_trial_graphic-1.png676380